World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
31352
World Ranking
11731
National Ranking
436

Research.com Recognitions

  • 1992 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Silvio Garattini is affiliated with the Mario Negri Institute for Pharmacological Research in Italy. Their research output is primarily situated within the field of Medicine, with a total of 69 publications. Garattini's work spans various subfields including Economics and Econometrics, Infectious Diseases, Pulmonary and Respiratory Medicine, Neurology, and Emergency Medicine.

The scientist's recent contributions include the following papers:

  • The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines, 2021, Nature Nanotechnology
  • Switching Among Biosimilars: A Review of Clinical Evidence, 2022, Frontiers in Pharmacology
  • Surface plasmon resonance unveils important pitfalls of enzyme-linked immunoassay for the detection of anti-infliximab antibodies in patients' sera, 2021, Scientific Reports
  • Effectiveness, Tolerability and Prescribing Choice of Antiviral Molecules Molnupiravir, Remdesivir and Nirmatrelvir/r: A Real-World Comparison in the First Ten Months of Use, 2023, Viruses
  • Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial, 2021, European Journal of Cancer

Garattini frequently publishes in several venues, notably:

  • European Journal of Clinical Pharmacology
  • PubMed
  • Frontiers in Pharmacology
  • Viruses
  • Università degli Studi di Trento

Their work extensively covers topics such as Health Systems, Economic Evaluations, Quality of Life; Pharmaceutical Economics and Policy; COVID-19 Clinical Research Studies; Pharmaceutical studies and practices; SARS-CoV-2 and COVID-19 Research; Long-Term Effects of COVID-19; and Gastric Cancer Management and Outcomes.

Garattini has collaborated often with the following researchers:

  • Cosmo Del Borgo
  • Anna Carraro
  • Miriam Lichtner
  • Rita Banzi
  • Raffaella Marocco

Among recognitions, Garattini was named a Fellow of the American Association for the Advancement of Science (AAAS) in 1992.

Best Publications

  • How to increase value and reduce waste when research priorities are set

    Iain Chalmers;Michael B Bracken;Ben Djulbegovic;Silvio Garattini

  • Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus

    Maria Grazia De Simoni;Carlo Perego;Teresa Ravizza;Daniela Moneta

  • Prognosis of untreated patients with idiopathic membranous nephropathy

    Arrigo Schieppati;Lidia Mosconi;Annalisa Perna;Giuliano Mecca

  • Caffeine disposition after oral doses

    Maurizio Bonati;Maurizio Bonati;Roberto Latini;Roberto Latini;Ferruccio Galletti;Ferruccio Galletti;John F Young;John F Young

  • Clinical pharmacokinetics of diazepam.

    Marinella Mandelli;Gianni Tognoni;Silvio Garattini

  • Studies on behavioral and biochemical changes in rats after lesion of midbrain raphé

    W. Kostowski;E. Giacalone;S. Garattini;L. Valzelli

  • The mechanism of action of fenfluramine.

    S Garattini;W Buczko;A Jori;R Samanin

  • Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.

    Jakub Adamski;Brian Godman;Brian Godman;Brian Godman;Gabriella Ofierska-Sujkowska;Bogusława Osińska

  • Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium.

    Alessandro Nobili;Silvio Garattini;Pier Mannuccio Mannucci

  • m-Chlorophenylpiperazine: A central serotonin agonist causing powerful anorexia in rats

    R. Samanin;T. Mennini;A. Ferraris;C. Bendotti

  • Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat

    S. Caccia;M. Cappi;C. Fracasso;S. Garattini

  • Tianeptine, a selective enhancer of serotonin uptake in rat brain.

    T. Mennini;E. Mocaer;S. Garattini

  • Non-inferiority trials are unethical because they disregard patients' interests.

    Silvio Garattini;Vittorio Bertele

  • Biochemical pharmacology of the anorectic drug fenfluramine: a review

    S. Garattini;S. Cactia;T. Mennini;R. Samanin

  • Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system

    S. Garattini;T. Mennini;C. Bendotti;R. Invernizzi

  • Interspecies Comparison of In Vivo Caffeine Pharmacokinetics in Man, Monkey, Rabbit, Rat and Mouse

    M. Bonati;R. Latini;G. Tognoni;J. F. Young

  • The effects of selective lesioning of brain serotonin or catecholamine containing neurones on the anorectic activity of fenfluramine and amphetamine.

    R. Samanin;D. Ghezzi;L. Valzelli;S. Garattini

  • Effects of new smoking regulations in Italy

    S. Gallus;P. Zuccaro;P. Colombo;G. Apolone

  • Immunosuppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in strains of mice with different susceptibility to induction of aryl hydrocarbon hydroxylase

    Annunciata Vecchi;Marina Sironi;Maria Antonia Canegrati;Martino Recchia

  • Why rare diseases are an important medical and social issue. Commentary

    Giuseppe Remuzzi;Silvio Garattini;Arrigo Schieppati;Jan-Inge Henter

Frequent Co-Authors

Rosario Samanin
Rosario Samanin Mario Negri Institute for Pharmacological Research
Mario Salmona
Mario Salmona Mario Negri Institute for Pharmacological Research
Roberto Fanelli
Roberto Fanelli Mario Negri Institute for Pharmacological Research
Giuseppe Remuzzi
Giuseppe Remuzzi Mario Negri Institute for Pharmacological Research
Corrado Barbui
Corrado Barbui University of Verona
Carlo La Vecchia
Carlo La Vecchia University of Milan
Maurizio D'Incalci
Maurizio D'Incalci Humanitas University
Alberto Mantovani
Alberto Mantovani Humanitas University
Gianni Tognoni
Gianni Tognoni University of Milan
Sergio Bernasconi
Sergio Bernasconi University of Parma

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens up a variety of promising career options, both in clinical and administrative roles. Many students choose to pursue related online degrees that offer flexibility and fast-tracked options for professional growth.

For those interested in leadership or management positions, consider exploring cahme accredited online healthcare administration programs. These programs prepare you for executive roles in hospitals, clinics, and other medical organizations.

Registered nurses can advance their education through an rn to bsn without clinicals program, providing a convenient pathway to higher qualifications and increased responsibilities—often without the need for in-person clinical hours.

Nurses seeking advanced practice roles might consider the fastest msn to dnp program, allowing for a rapid transition into leadership, education, or specialized clinical practice.

If balancing work and study is key, you may also be interested in a dnp program without clinical hours. These programs are designed for working professionals who want to attain the highest level of nursing education with a more flexible approach.

Best Scientists Citing Silvio Garattini

Trending Scientists

Recently Published Articles